Correction: Integration of multiparametric MRI and clinical indicators to predict response to immune-targeted therapy in patients with advanced hepatocellular carcinoma - Summary - MDSpire

Correction: Integration of multiparametric MRI and clinical indicators to predict response to immune-targeted therapy in patients with advanced hepatocellular carcinoma

  • By

  • Shuai Han

  • Fan Meng

  • Li-feng Wang

  • Peng-rui Gao

  • Hong-kai Zhang

  • Jin-rong Qu

  • May 27, 2026

  • 0 min

Share

Objective:

To correct the omission of the funder in the original article.

Key Findings:
  • The funder 'Henan Province Central Plains Talent Program (Nurturing talent Series) (No. RS0011)' was omitted in the original publication.
Interpretation:

The original article has been updated to include the missing funding information.

Limitations:
Conclusion:

The article has been corrected to reflect the accurate funding source.

Original Source(s)

Correction: Integration of multiparametric MRI and clinical indicators to predict response to immune-targeted therapy in patients with advanced hepatocellular carcinoma

  • by Shuai Han, Fan Meng, Li-feng Wang, Peng-rui Gao, Hong-kai Zhang, Jin-rong Qu

  • May 27, 2026

Related Content

From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer

Financial Hardship and Nonadherence to Lifestyle and Surveillance in Childhood Cancer Survivors

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant